Vanda Pharmaceuticals Inc. (VNDA), Thursday announced that it has received a revised proposal from Future Pak, LLC to takeover the company for $8.50-$9.00 per share in cash plus certain Contingent Value Rights.
The biopharmaceutical company added that the new proposal will be carefully reviewed and evaluated by the board before making a final decision.
Currently, Vanda's stock is moving up 13.20 percent, to $6.70 over the previous close of $5.92 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.